[A Case of Successful Treatment of Recurrent Liver Metastases from Mixed Adenoneuroendocrine Carcinoma of the Pancreas with Everolimus Administration].
A 66-year-old man was admitted to undergo investigation for body weight loss. He was diagnosed with pancreatic neuroendocrine carcinoma, and a pancreaticoduodenectomy was performed. Three months after surgery, multiple recurrent liver metastases were observed on CT. We administered the cisplatin(CDDP)/irinotecan(CPT-11)regimen, but decided to discontinue the regimen because of adverse events. One month later, administration of everolimus(10mg/day)was initiated. Lesion loss was observed after 8 months, and the patient achieved a complete response(CR)without abnormal accumulation of FDG on PET-CT. Administration of everolimus was discontinued after 13 months because of peripheral neuropathy. Despite drug withdrawal, the patient has remained in remission for more than 3 years. Everolimus is considered an effective treatment for MANEC from NEC.